<DOC>
	<DOCNO>NCT01238874</DOCNO>
	<brief_summary>The Latin America CRT Study prospective , multicenter , interventional post-market release study conduct Latin America . The geography include Puerto Rico Caribbean , Mexico Central America , South America .</brief_summary>
	<brief_title>Latin America Cardiac Resynchronization Therapy Study</brief_title>
	<detailed_description>The purpose study provide local evidence regard Cardiac Resynchronization Therapy ( CRT ) , pace defibrillation device across Latin America . The primary objective focus change leave ventricular heart size function measurement subject receive CRT therapy . The following additional parameter also collect : - Data referral pattern Latin America ; - Data device implant ( include delivery system , device information , lead information ) ; - Clinical data subject outcome change ( improve , unchanged , worsen ) heart failure status assess heart failure ( HF ) hospitalization , New York Heart Association ( NYHA ) class , mortality , Quality Life ( QOL ) measure Patient Global Assessment ;</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Implant new CRTD CRTP device ( firsttime implant ) , ACC/AHA/HRS/ESC guideline implant , NYHA Class II , III IV , QRS duration &gt; 120 m , LVEF &lt; 35 % , Receiving optimal medical/drug therapy , Able give write informed consent , Are &gt; 21 year age , Must able return followup visit require , Are pregnant plan get pregnant within next 6 month , Have physical limitation perform Echo study Previous exist CRT system implant , Unwilling unable comply specify followup schedule , Enrolled intend participate another device study course study require specific treatment device programming , Medical condition may limit life expectancy &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>